Loading university
Matthew R. Parsek — Dr. Matthew R. Parsek's lab at the University of Washington studies how bacteria like Pseudomonas aeruginosa form biofilms and establish infections. They specifically investigate how different internal signals affect the bacteria's ability to stick to surfaces and communicate with each other. Understanding these processes can help develop new therapies for managing infections.
Jeffrey S Chamberlain — Dr. Jeffrey Chamberlain's lab focuses on developing advanced gene therapies for Duchenne muscular dystrophy (DMD), a severe genetic disorder. The lab aims to improve the delivery and function of dystrophin proteins, utilizing innovative vector technologies. By designing new methods for gene replacement and editing, the research seeks to enhance the effectiveness and safety of treatments for DMD and related neuromuscular disorders.
Bruce Colston Trapnell — Professor Bruce Trapnell's lab focuses on using advanced software tools to analyze single-cell genomics, particularly in the study of embryonic development and disease mechanisms. They work on generating and validating new datasets that provide insights into how cell types and genes function at a detailed level. By developing computational algorithms, the lab aims to better understand how genetic and environmental factors influence cell behavior in complex tissues.
Jeffrey Michael Bethony — Dr. Jeffrey Michael Bethony's lab at George Washington University focuses on improving understanding and treatment of anal cancer, particularly as it relates to individuals living with HIV. His team manages the AIDS and Cancer Specimen Resource, which collects and distributes a large number of biospecimens for research. The goal is to enhance screening, prevention, and treatment protocols through careful analysis of specimen data, ultimately benefiting public health initiatives related to HPV-associated cancers.
Lijie Grace Zhang — Dr. Lijie Grace Zhang's lab focuses on developing innovative engineering solutions to address challenges in cardiac tissue repair, particularly after heart attacks. They create advanced 3D bioprinting technologies to engineer functional myocardial tissue that can mimic the heart's natural structure and function. This research aims to improve treatment options for patients suffering from heart failure and enhance our understanding of cardiac regeneration.
Michael Ilya Bukrinsky — Dr. Michael Bukrinsky's lab focuses on understanding how HIV infection affects the brain, particularly in relation to neurological disorders that arise despite effective anti-retroviral treatments. They are investigating the role of a protein called Nef in disrupting cholesterol metabolism in neurons, which may contribute to cognitive impairments experienced by individuals living with HIV. The ultimate goal is to identify potential therapeutic strategies to mitigate these neurological issues and enhance the quality of life for affected patients.
Rong Li — Dr. Rong Li's lab at George Washington University focuses on understanding how adipocytes, a type of fat cell, influence breast cancer and antitumor immunity. The research explores the roles of PD-L1 in the breast tumor microenvironment and seeks to reveal new mechanisms by which T cells respond to the tumor environment, especially in the context of obesity. By investigating these interactions, the lab aims to improve immunotherapy strategies for breast cancer, particularly for patients struggling with obesity-related health challenges.
Luyao Lu — Dr. Luyao Lu's lab focuses on developing innovative wireless implantable devices for studying heart conditions, particularly arrhythmias and heart failure. The team creates soft, flexible systems that can monitor and influence heart activity in real-time, providing insights into the complex mechanisms underlying these diseases. Their goal is to improve diagnostic and therapeutic strategies for heart disease and enhance the quality of life for affected patients.
Tristan Xavier Jordan — Tristan Xavier Jordan's lab at the University of Washington focuses on understanding how microbial eukaryotes, particularly Acanthamoeba, defend against viral infections. By investigating the antiviral systems of these organisms, the lab aims to uncover new microbial antiviral strategies and technologies that could have significant implications for biotechnology and medicine. The research combines various advanced techniques, including protein structure prediction and metatranscriptomics, to explore the complex interactions between viruses and their eukaryotic hosts.